An interventional study of Electroacupuncture and Sham electroacupuncture in Disorder of Consciousness and Electroacupuncture, sponsored by The Second Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine. Recruiting at 1 site in China. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-18.
Sponsored by The Second Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 70 studies in Consciousness Disorders with a site in China — 30 open to participants now, 31 under way, 1 of them phase 3. Consciousness Disorders · China.
Among the 70 studies in Consciousness Disorders with a site in China, this one is the 22nd largest by planned enrollment of the 40 interventional ones that give a count, is one of 10 that started in 2024, is one of 36 with no phase, reaches primary completion later than 18 of the 30 other live ones, and was the 45th registered.
291 studies on the registry are indexed under Consciousness Disorders; 109 are open to participants now.
Browse Consciousness Disorders studies →30 of the 70 studies in Consciousness Disorders with a site in China are open now. Recruiting first, the newest first:
Beijing Tiantan Hospital · Sites in China
Ages 18–75
Xijing Hospital · Sites in China
Ages 18–80
Zhujiang Hospital · Sites in China
Ages 18–70
Guangzhou General Hospital of Guangzhou Military Command · Sites in China
Ages 3–65
Xijing Hospital · Sites in China
Ages 18–65
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 74 Consciousness Disorders studies recruiting now, 31 (42%) set no upper age limit and 24 (32%) stop at 75 or younger; 12 take children under 18; 15 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
70 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 2 · Phase 3 1 · Phase 4 2
First in 2008; this study’s year is marked. 10 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 50 is close to the median of 47 across 192 interventional studies indexed under Consciousness Disorders.
Median enrollment 60 across the 40 interventional studies, 120 across the 30 observational. Of the 27 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 70 have an industry lead sponsor. The 10 most frequent:
The Second Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine is the lead sponsor of 2 studies on the registry; 2 are open to participants now.
The Second Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine has 1 study filed under Consciousness Disorders — fewer than ten, so there is no comparison to draw.
8 of the studies in Consciousness Disorders with a site in China that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06406413First Affiliated Hospital of Zhejiang UniversityMicro-movements in Patients With Prolonged Disorders of Consciousness | 2026-12 |
| NCT06088628First Affiliated Hospital of Zhejiang UniversityMicro-expressions in Patients With Prolonged Disorders of Consciousness | 2026-12 |
| NCT06268236The Second Affiliated Hospital, Guangzhou University of Traditional Chinese MedicineElectro-acupuncture to Treat Disorder of Consciousness | 2026-12-31 |
| NCT07183670Hongying Jiang, MDA Speaking-Valve-Based Decannulation Protoco for Patients With a Prolonged Disorders of Consciousness | 2027-02-01 |
| NCT07173634Hongying Jiang, MDSpeaking Valve Trial vs. Capping Trial for Tracheostomy Decannulation in Prolonged Disorders of Consciousness | 2027-02-01 |
Add all 8 to your calendar (.ics) → With an account.
Among the 70 studies in Consciousness Disorders with a site in China, from their registry updates:
This tab as a report to print or save as PDF → With an account.
With the rapid development of life support technology, more and more people can survive severe brain injury. Some survivors regain consciousness after a period of coma, however, many patients develop prolonged disorders of consciousness (DOC), which poses a therapeutic challenge for clinicians and a heavy burden for their families. The investigators design an Electro-acupuncture to treat disorder of consciousness (AcuDoc) trial with the aim of validating the clinical effect of electroacupuncture in treating DOC and exploring its therapeutic mechanisms by integrating EEG, neuroimaging, evoked potential tests, and behavioral assessments.
The AcuDoc trial is a single-center, prospective, triple masking, randomized, sham electroacupuncture-controlled study. A total of 50 adult patients with DOC and 25 healthy subjects will be enrolled in the study . Patients will be randomized into electroacupuncture (EA) group or sham EA group (1:1). All patients will receive EA or sham-EA treatment in the supine position at 9 am for 30 minutes once a day for consecutive 14 days and healthy subjects will receive no treatments. The primary objective is to determine the therapeutic benefit of electroacupuncture on the recovery of consciousness in patients with DOC after a 2-week intervention. Key secondary objective is to investigate the effect of electroacupuncture on the circuitry of consciousness using a multimodal approach integrating EEG, neuroimaging (rs-fMRI, amide proton transfer imaging, intravoxel incoherent motion imaging, neurite orientation dispersion and density imaging), and evoked potentials (SEP, BAEP). Other secondary outcomes include the effect of EA on the assessment of brain-computer interface after a 2-week intervention and on the Glasgow Outcome Scale-Extended score at 30 days and 90 days .
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A drug or device being studied in a clinical trial.
It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Investigational drug or device
A drug or device being studied in a clinical trial.
It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients in EA group receive acupuncture at Shuigou (also known as Renzhong, GV26) and Yintang (updated number GV24+, previous number GV29). Paired electrodes from the EA apparatus are clipped to the needle handles at Shuigou and Yintang. The electroacupuncture stimulation lasts for 30 minutes with a wave of rarefaction and condensation (10 Hz / 50 Hz) and a current intensity of the maximum withstand current within 7mA. All patients receive EA at 9 am for 30 minutes once a day for consecutive 14 days.
Other: Electroacupuncture
Patients in sham-EA group receive sham-EA at sham-Shuigou and sham-Yintang.Acupuncture needles are inserted into the adhesive pads but do not pierce the skin. Paired electrodes from the EA apparatus via sham connecting cords are clipped to the needle handles at sham-Shuigou and sham-Yintang. The sham connecting cords are similar in appearance to the normal ones, but the inner wires in sham connecting cords are cut off and cannot conduct electricity. All patients receive sham-EA at 9 am for 30 minutes once a day for consecutive 14 days.
Other: Sham electroacupuncture
Electro-acupuncture at Shuigou and Yintang.
Sham-EA at sham-Shuigou and sham-Yintang.
Coma Recovery Scale - Revised score
0 - 23, a higher score indicates a better level of consciousness
Time frame: after 14 days of EA or sham-EA treatment
phase locking value
measured by electroencephalogram
Time frame: after 14 days of EA or sham-EA treatment
amplitude of low-frequency fluctuation
measured by resting-state functional magnetic resonance imaging
Time frame: after 14 days of EA or sham-EA treatment
Amide proton transfer-weighted signal
measured by amide proton transfer imaging
Time frame: after 14 days of EA or sham-EA treatment
f value
measured by intravoxel incoherent motion imaging
Time frame: after 14 days of EA or sham-EA treatment
neurite density index
measured by neurite orientation dispersion and density imaging
Time frame: after 14 days of EA or sham-EA treatment
latency value of N20
measured by somatosensory evoked potential biomarkers
Time frame: after 14 days of EA or sham-EA treatment
latency between III and V potentials
measured by brainstem auditory evoked potential
Time frame: after 14 days of EA or sham-EA treatment
Glasgow Outcome Scale-Extended score
1 - 8, a higher score indicates better functional recovery from brain injury
Time frame: 30 days after randomization
Glasgow Outcome Scale-Extended score
1 - 8, a higher score indicates better functional recovery from brain injury
Time frame: 90 days after randomization
brain-computer interface accuracy
measured by electroencephalogram-based brain-computer interface experiment
Time frame: after 14 days of EA or sham-EA treatment
Plan to share: No — The detailed datasets used and/or analyzed during the current study are available upon reasonable request.
Started Jan 2024 (actual). Primary completion is estimated for Dec 2026, 35 months after the start.
Of 90 non-industry interventional studies with no phase under Consciousness Disorders, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 64. This study's planned 35 months is above that.
Counting every sponsor, half of 95 studies reached it within 19 months; a quarter within 8 and three quarters within 52.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 18, 2026: primary completion Jan 2026 → Dec 2026 and completion Jan 2026 → Dec 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
The Second Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine